These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 89971

  • 1. Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release.
    Gourdji D, Bataille D, Vauclin N, Grouselle D, Rosselin G, Tixier-Vidal A.
    FEBS Lett; 1979 Aug 01; 104(1):165-8. PubMed ID: 89971
    [No Abstract] [Full Text] [Related]

  • 2. Adenosine 3',5'-cyclic monophosphate-dependent release of prolactin from GH3 pituitary tumour cells. A quantitative analysis.
    Guild S, Drummond AH.
    Biochem J; 1983 Dec 15; 216(3):551-7. PubMed ID: 6199014
    [Abstract] [Full Text] [Related]

  • 3. Pertussis toxin blocks the inhibitory effects of somatostatin on cAMP-dependent vasoactive intestinal peptide and cAMP-independent thyrotropin releasing hormone-stimulated prolactin secretion of GH3 cells.
    Yajima Y, Akita Y, Saito T.
    J Biol Chem; 1986 Feb 25; 261(6):2684-9. PubMed ID: 2869031
    [Abstract] [Full Text] [Related]

  • 4. Effects of VIP, TRH, GABA and dopamine on prolactin release from superfused rat anterior pituitary cells.
    Matsushita N, Kato Y, Shimatsu A, Katakami H, Yanaihara N, Imura H.
    Life Sci; 1983 Mar 14; 32(11):1263-9. PubMed ID: 6132313
    [Abstract] [Full Text] [Related]

  • 5. The mechanisms by which vasoactive intestinal peptide (VIP) and thyrotropin releasing hormone (TRH) stimulate prolactin release from pituitary cells.
    Bjøro T, Sand O, Ostberg BC, Gordeladze JO, Torjesen P, Gautvik KM, Haug E.
    Biosci Rep; 1990 Apr 14; 10(2):189-99. PubMed ID: 2162702
    [Abstract] [Full Text] [Related]

  • 6. [A study on the prolactin releasing mechanism using an in vitro perfusion system with a cell column of cultured rat anterior pituitary cells].
    Kageyama J.
    Nihon Naibunpi Gakkai Zasshi; 1984 Oct 20; 60(10):1243-54. PubMed ID: 6440813
    [Abstract] [Full Text] [Related]

  • 7. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
    Balsa JA, Cacicedo L, Lara JI, Lorenzo MJ, Pazos F, Sanchez-Franco F.
    Endocrinology; 1996 Jan 20; 137(1):144-50. PubMed ID: 8536606
    [Abstract] [Full Text] [Related]

  • 8. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
    Apfelbaum ME.
    Neuroendocrinology; 1998 Jan 20; 67(1):45-50. PubMed ID: 9485168
    [Abstract] [Full Text] [Related]

  • 9. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.
    Enjalbert A, Epelbaum J, Arancibia S, Tapia-Arancibia L, Bluet-Pajot MT, Kordon C.
    Endocrinology; 1982 Jul 20; 111(1):42-7. PubMed ID: 6123432
    [Abstract] [Full Text] [Related]

  • 10. On the involvement of cyclic AMP and extracellular Ca2+ in the regulation of hormone release from rat pituitary tumour (GH3) cells in culture.
    Sletholt K, Haug E, Gautvik KM.
    Biosci Rep; 1987 Feb 20; 7(2):93-105. PubMed ID: 2443198
    [Abstract] [Full Text] [Related]

  • 11. Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+.
    Bjøro T, Ostberg BC, Sand O, Gordeladze J, Iversen JG, Torjesen PA, Gautvik KM, Haug E.
    Mol Cell Endocrinol; 1987 Feb 20; 49(2-3):119-28. PubMed ID: 2435588
    [Abstract] [Full Text] [Related]

  • 12. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
    Dorflinger LJ, Schonbrunn A.
    Endocrinology; 1983 Nov 20; 113(5):1541-50. PubMed ID: 6194974
    [Abstract] [Full Text] [Related]

  • 13. Vasoactive intestinal peptide causes a calcium-dependent stimulation of prolactin secretion in GH4C1 cells.
    Bjøro T, Haug E, Sand O, Gautvik KM.
    Mol Cell Endocrinol; 1984 Aug 20; 37(1):41-50. PubMed ID: 6432604
    [Abstract] [Full Text] [Related]

  • 14. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC, Chapman LP, Morris JF.
    J Neuroendocrinol; 2007 Aug 20; 19(8):605-13. PubMed ID: 17620102
    [Abstract] [Full Text] [Related]

  • 15. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
    Michalkiewicz M, Suzuki M, Kato M.
    Endocrinology; 1987 Jul 20; 121(1):371-7. PubMed ID: 2885177
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Dexamethasone regulation of the prolactin release induced by vasoactive intestinal peptide (VIP)].
    Rotsztejn W, Benoist L, Besson J, Duval J.
    C R Seances Acad Sci D; 1980 Mar 24; 290(12):791-3. PubMed ID: 6769606
    [Abstract] [Full Text] [Related]

  • 19. MMQ cells: a model for evaluating the role of G proteins in the modulation of prolactin release.
    Forget H, Painson JC, Drews RT, Lagacé G, Collu R.
    Mol Cell Endocrinol; 1993 Jun 24; 93(2):125-33. PubMed ID: 7688703
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.